ACSM4 (Gene)

Organism:

Homo sapiens

Synonyms:ACSM4, ENTREZ:341392, HGNC:32016, MIM:614360, NM_001080454, NP_001073923, acyl-CoA synthetase medium chain family member 4

Omim:OMIM:614360

Id:ENSG00000215009

Hgnc:HGNC:32016

Entrez:341392

Ensembl:ENSG00000215009

Description:acyl-CoA synthetase medium chain family member 4

Predicted to enable decanoate-CoA ligase activity and fatty-acyl-CoA synthase activity. Predicted to be involved in acyl-CoA metabolic process and fatty acid biosynthetic process. Predicted to be active in mitochondrial matrix. [provided by Alliance of Genome Resources, Apr 2022]

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View ACSM4's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with ACSM4.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using ACSM4.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for ACSM4.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with ACSM4.

Results found

Linked to

	Label	Description
	GSE252944 AKT inhibition 7 v 9 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE115384 CELSR2 knockdown 2 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE224105 GSE224108 zearalenone 3 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE199107 tryptophan 3 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE83266 ICG-001 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE252944 AKT inhibition 7 v 8 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE114492 GSE153671 KMT2D inhibition 5 v 11 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE144759 FLT3 inhibition 6 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE115384 CELSR2 knockdown 5 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE252944 AKT inhibition 7 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS

GSE252944 AKT inhibition 7 v 9 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE115384 CELSR2 knockdown 2 v 7 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE224105 GSE224108 zearalenone 3 v 0 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE199107 tryptophan 3 v 5 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE83266 ICG-001 1 v 0 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE252944 AKT inhibition 7 v 8 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE114492 GSE153671 KMT2D inhibition 5 v 11 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE144759 FLT3 inhibition 6 v 3 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE115384 CELSR2 knockdown 5 v 7 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE252944 AKT inhibition 7 v 6 human dn

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.